Why Sprouts Farmers Market Lost a Major Investor—But Gained New Opportunity

In mid-February 2026, Promethos Capital completed a full exit from its Sprouts Farmers Market holdings, selling all 34,935 shares worth approximately $3.8 million at the quarterly average price. According to the SEC filing from Feb. 13, 2026, this decision represented a complete liquidation of what had been a 1.02% position of the fund’s assets under management. The move raised immediate questions: if professional investors are bailing out, should ordinary shareholders follow?

The answer, surprisingly, points in the opposite direction.

Understanding the Fund’s Exit

Promethos Capital’s decision to unwind its entire Sprouts position didn’t happen suddenly. The fund originally entered at roughly $48 per share during Q4 2023, then added to the position two quarters later when momentum was clearly building. It later trimmed roughly half its shares when prices more than doubled—a rational profit-taking move typical of disciplined fund management.

The final exit came after Sprouts stock retreated 53% over just six months, though it remained down 60.9% from its peak the previous year. At the time of exit, shares traded at $68.96, underperforming the S&P 500 by 73 percentage points.

Without public statements on the decision, observers can reasonably infer that volatility and short-term pressure likely influenced the exit more than fundamental deterioration. Professional funds face quarterly redemptions and performance scrutiny—pressures that don’t apply the same way to long-term individual investors.

The Disconnect Between Price and Fundamentals

Here’s where the investment thesis becomes interesting. At $68.96 per share, Sprouts trades at just 13 times trailing earnings and 15 times free cash flow—a remarkable discount given the company’s trajectory. By comparison, when major technology stocks appear “cheap” to institutional investors, valuations are typically 20-30x earnings.

Sprouts’ recent performance tells a different story from its share price:

• Revenue growth: Consistent double-digit annual growth over the past decade
• Profitability: TTM net income of $513.45 million on $8.65 billion in revenue (5.9% net margin)
• Scale: 464 locations across 24 states with actively expanding into 9 additional states
• Market position: A market capitalization of $6.71 billion for a high-growth specialty grocery operator

The company operates in a structurally advantaged niche—health-conscious consumers willing to pay premiums for organic, specialty, and natural products. This positioning has proven resilient even through economic cycles.

The Innovation Advantage Nobody Talks About

Beyond the raw numbers, Sprouts demonstrates capabilities that traditional grocers simply lack. The company introduced 7,100 new products and launched 300 private-label offerings in 2024 alone. With 70% of inventory focused on attribute-driven products—kosher, organic, non-GMO, gluten-free, vegan, and similar categories—the retailer has built genuine differentiation.

This isn’t accidental. Sprouts operates like a lean innovation machine, constantly testing new healthy product categories to identify emerging consumer trends. That capability sustained revenue growth even when major economic headwinds challenged the retail sector.

Long-Term Runway Versus Short-Term Volatility

Perhaps most compelling is the expansion opportunity. Sprouts management believes the company can reach 1,400 locations over the long term, up from today’s 464. Even conservative penetration of this addressable market would imply significant unit growth and corresponding earnings expansion—exactly the kind of scenario that typically justifies premium valuations.

Promethos Capital’s exit, then, reveals less about Sprouts’ fundamental quality and more about the different pressures facing professional fund managers. Quarterly returns matter. Quarterly redemptions loom. The time horizon for fund performance is measured in months, not decades.

Is This a Buyer’s Opportunity in Sprouts?

The investment case for Sprouts hinges on a simple premise: the market is pricing in substantial disappointment despite consistent execution and a clear path to profitable expansion. At current valuations, the stock offers asymmetric risk-reward for patient capital with a multi-year horizon.

Investors holding Sprouts need not panic at Promethos Capital’s departure. If anything, the fund’s exit—driven by near-term volatility rather than fundamental deterioration—may signal exactly when patient investors should lean in rather than sell.